Ernest L Mazzaferri

Summary

Affiliation: Kathleen D. Schaum and Associates
Country: USA

Publications

  1. ncbi Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Ernest L Mazzaferri
    Department of Internal Medicine, University of Florida, Gainesville 32608 4653, USA
    J Clin Endocrinol Metab 87:1490-8. 2002
  2. ncbi Management of low-risk differentiated thyroid cancer
    Ernest L Mazzaferri
    The Department of Medicine, Division of Endocrinology, University of Florida, Gainesville, Florida 32608 4653, USA
    Endocr Pract 13:498-512. 2007
  3. ncbi Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin
    E L Mazzaferri
    Adjunct Professor of Medicine, University of Florida, USA
    Endocr Relat Cancer 9:227-47. 2002
  4. ncbi A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
    Richard T Kloos
    Division of Endocrinology, Shands Hospital, 1600 SW Archer Road, P O Box 100226, Gainesville, Florida 32610 0226, USA
    J Clin Endocrinol Metab 90:5047-57. 2005
  5. ncbi External beam radiotherapy for differentiated thyroid cancer
    Kenyon M Meadows
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA
    Am J Otolaryngol 27:24-8. 2006
  6. ncbi Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions
    E L Mazzaferri
    Department of Internal Medicine, The Ohio State University, Columbus, USA
    Thyroid 10:767-78. 2000
  7. ncbi Gonadal damage from 131I therapy for thyroid cancer
    Ernest L Mazzaferri
    Division of Endocrinology, Shands Hospital, University of Florida, Gainesville, FL 32610, USA
    Clin Endocrinol (Oxf) 57:313-4. 2002
  8. ncbi A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
    E L Mazzaferri
    Division of Endocrinology, Shands Hospital, Gainesville, Florida 32610, USA
    J Clin Endocrinol Metab 88:1433-41. 2003
  9. ncbi Empirically treating high serum thyroglobulin levels
    Ernest L Mazzaferri
    University of Florida Gainesville, Florida, USA
    J Nucl Med 46:1079-88. 2005
  10. ncbi The therapeutic management of differentiated thyroid cancer
    JENNIFER A SIPOS
    University of Florida, 1600 Archer Road, PO Box 100226, Gainesville, FL 32610, USA
    Expert Opin Pharmacother 9:2627-37. 2008

Collaborators

Detail Information

Publications26

  1. ncbi Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Ernest L Mazzaferri
    Department of Internal Medicine, University of Florida, Gainesville 32608 4653, USA
    J Clin Endocrinol Metab 87:1490-8. 2002
    ..An elevated rhTSH-stimulated Tg greater than 2 ng/ml warrants further study...
  2. ncbi Management of low-risk differentiated thyroid cancer
    Ernest L Mazzaferri
    The Department of Medicine, Division of Endocrinology, University of Florida, Gainesville, Florida 32608 4653, USA
    Endocr Pract 13:498-512. 2007
    ....
  3. ncbi Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin
    E L Mazzaferri
    Adjunct Professor of Medicine, University of Florida, USA
    Endocr Relat Cancer 9:227-47. 2002
    ....
  4. ncbi A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
    Richard T Kloos
    Division of Endocrinology, Shands Hospital, 1600 SW Archer Road, P O Box 100226, Gainesville, Florida 32610 0226, USA
    J Clin Endocrinol Metab 90:5047-57. 2005
    ..Testing for residual differentiated thyroid carcinoma relies heavily upon recombinant human (rh)TSH-stimulated serum thyroglobulin (Tg) levels, but the positive predictive value is often low...
  5. ncbi External beam radiotherapy for differentiated thyroid cancer
    Kenyon M Meadows
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA
    Am J Otolaryngol 27:24-8. 2006
    ..To evaluate the efficacy of external beam radiation therapy (EBRT) for differentiated thyroid carcinomas...
  6. ncbi Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions
    E L Mazzaferri
    Department of Internal Medicine, The Ohio State University, Columbus, USA
    Thyroid 10:767-78. 2000
    ..Formal clinical investigations now planned to provide guidelines for the use of rhTSH for therapeutic 131I portend a new set of effective therapeutic paradigms for the management of differentiated thyroid cancer...
  7. ncbi Gonadal damage from 131I therapy for thyroid cancer
    Ernest L Mazzaferri
    Division of Endocrinology, Shands Hospital, University of Florida, Gainesville, FL 32610, USA
    Clin Endocrinol (Oxf) 57:313-4. 2002
  8. ncbi A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
    E L Mazzaferri
    Division of Endocrinology, Shands Hospital, Gainesville, Florida 32610, USA
    J Clin Endocrinol Metab 88:1433-41. 2003
    ....
  9. ncbi Empirically treating high serum thyroglobulin levels
    Ernest L Mazzaferri
    University of Florida Gainesville, Florida, USA
    J Nucl Med 46:1079-88. 2005
  10. ncbi The therapeutic management of differentiated thyroid cancer
    JENNIFER A SIPOS
    University of Florida, 1600 Archer Road, PO Box 100226, Gainesville, FL 32610, USA
    Expert Opin Pharmacother 9:2627-37. 2008
    ..The treatment of these tumors rests on a fine balance of providing care that reflects the anticipated course of the disease without overtreating the patient or providing reassurance that is unfounded...
  11. ncbi What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?
    Ernest L Mazzaferri
    The Ohio State University, USA
    Oncology (Williston Park) 23:579-88. 2009
    ..The natural history of papillary cancer is such that patients who achieve disease-free status after total thyroidectomy and radioiodine therapy usually achieve normal life expectancy...
  12. doi Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion?
    Ernest L Mazzaferri
    Medicine, Ohio State University, Division of Endocrinology, Ohio State University, Columbus, Ohio, USA
    Thyroid 18:597-602. 2008
    ..Decisions involving the management of patients with papillary microcarcinoma are complex. Here we review and consider the literature in this area including two studies published in this issue of Thyroid...
  13. doi Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial
    Ernest L Mazzaferri
    Division of Cardiovascular Medicine, The Ohio State University Heart and Vascular Center, 473 West 12th Ave, Columbus, OH 43210 1252, USA
    Am Heart J 163:812-820.e1. 2012
    ..The aim of this study was to assess the feasibility, safety, and preliminary efficacy of a novel percutaneous left ventricular partitioning device (VPD) in patients with chronic heart failure (HF) and a prior anterior myocardial infarction...
  14. doi Approach to the pregnant patient with thyroid cancer
    Ernest L Mazzaferri
    The Ohio State University, Columbus, Ohio 43210, USA
    J Clin Endocrinol Metab 96:265-72. 2011
    ..There is concern about therapy for thyroid cancer during this period, including the timing of surgery, the use of levothyroxine, and the assessment of follow-up during gestation...
  15. pmc Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome
    Subha V Raman
    Ohio State University, Columbus, Ohio 43210, USA
    J Am Coll Cardiol 55:2480-8. 2010
    ..The aim of this study was to define the prevalence and significance of myocardial edema in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS)...
  16. pmc Managing thyroid microcarcinomas
    Ernest L Mazzaferri
    Division of Endocrinology, Shands Hospital, University of Florida, 4020 SW, 9rd Drive, Gainesville, FL 32608, USA
    Yonsei Med J 53:1-14. 2012
    ..The aim of this review is to summarize the clinical features of PTMC and identify the widely differing opinions concerning the diagnosis and management of these small ubiquitous thyroid tumors...
  17. ncbi The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules
    Rachel Redman
    Department of Pathology, University of Florida, Gainesville, Florida 32610 0275, USA
    Thyroid 16:55-60. 2006
    ..We believe this is a goal that training programs should strive to achieve...
  18. ncbi Diagnosis and management of medullary thyroid carcinoma
    Nicole Massoll
    Department of Pathology, University of Florida, PO Box 100275, Gainesville, FL 32610 0275, USA
    Clin Lab Med 24:49-83. 2004
    ..Moreover, new treatments for widespread MTC are necessary because current chemotherapy agents offer little benefit. New drugs that lock the action of tyrosine kinase offer some hope...
  19. ncbi Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter
    Xiaoqin Lin
    Department of Physiology and Cell Biology, Ohio State University, Columbus, Ohio 43210, USA
    J Clin Endocrinol Metab 89:2344-50. 2004
    ..Finally, Tg promoter activity was partially restored in malignant thyroid cells by forced expression of the paired domain-containing transcription factor (Pax-8), allowing the Cre/loxP system to mildly enhance radioiodide uptake...
  20. ncbi A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
    ..Levothyroxine (L-T4) withdrawal for thyroglobulin measurement and whole body scanning increases these tests' sensitivities but causes hypothyroidism. Recombinant human TSH (rhTSH) enables testing without L-T4 withdrawal...
  21. ncbi Changing paradigms in the follow-up of patients with differentiated thyroid cancer: an alternative to [18F]fluorodeoxyglucose positron emission tomographic scanning
    Ernest L Mazzaferri
    Endocr Pract 9:324-6. 2003
  22. pmc Expanding indications for recombinant human TSH in thyroid cancer
    Bryan R Haugen
    Thyroid 18:687-94. 2008
  23. doi Training, credentialing and re-credentialing for the performance of a thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference
    Britt Marie E Ljung
    Department of Pathology, University of California San Francisco, San Francisco, California 94143 1785, USA
    Diagn Cytopathol 36:400-6. 2008
    ..http://thyroidfna.cancer.gov/pages/info/agenda/)..
  24. ncbi Thyroid cancer in thyroglossal duct remnants: a diagnostic and therapeutic dilemma
    Ernest L Mazzaferri
    Thyroid 14:335-6. 2004
  25. ncbi Managing small thyroid cancers
    Ernest L Mazzaferri
    JAMA 295:2179-82. 2006
  26. ncbi Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine, MD, USA
    Thyroid 16:109-42. 2006